These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29505099)

  • 1. Higher levels of kallikrein-8 in female brain may increase the risk for Alzheimer's disease.
    Keyvani K; Münster Y; Kurapati NK; Rubach S; Schönborn A; Kocakavuk E; Karout M; Hammesfahr P; Wang YC; Hermann DM; Teuber-Hanselmann S; Herring A
    Brain Pathol; 2018 Nov; 28(6):947-964. PubMed ID: 29505099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic knockdown of Klk8 has sex-specific multi-targeted therapeutic effects on Alzheimer's pathology in mice.
    Herring A; Kurapati NK; Krebs S; Grammon N; Scholz LM; Voss G; Miah MR; Budny V; Mairinger F; Haase K; Teuber-Hanselmann S; Dobersalske C; Schramm S; Jöckel KH; Münster Y; Keyvani K
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):611-624. PubMed ID: 33341972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of excessive kallikrein-8 improves neuroplasticity in Alzheimer's disease mouse model.
    Münster Y; Keyvani K; Herring A
    Exp Neurol; 2020 Feb; 324():113115. PubMed ID: 31734318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
    Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
    Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 8. Associations between sex, body mass index and the individual microglial response in Alzheimer's disease.
    Biechele G; Rauchmann BS; Janowitz D; Buerger K; Franzmeier N; Weidinger E; Guersel S; Schuster S; Finze A; Harris S; Lindner S; Albert NL; Wetzel C; Rupprecht R; Rominger A; Palleis C; Katzdobler S; Burow L; Kurz C; Zaganjori M; Trappmann LK; Goldhardt O; Grimmer T; Haeckert J; Keeser D; Stoecklein S; Morenas-Rodriguez E; Bartenstein P; Levin J; Höglinger GU; Simons M; Perneczky R; Brendel M
    J Neuroinflammation; 2024 Jan; 21(1):30. PubMed ID: 38263017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice.
    Herring A; Münster Y; Akkaya T; Moghaddam S; Deinsberger K; Meyer J; Zahel J; Sanchez-Mendoza E; Wang Y; Hermann DM; Arzberger T; Teuber-Hanselmann S; Keyvani K
    Alzheimers Dement; 2016 Dec; 12(12):1273-1287. PubMed ID: 27327541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis.
    Xue D; Zhao M; Wang YJ; Wang L; Yang Y; Wang SW; Zhang R; Zhao Y; Liu RT
    Neurobiol Dis; 2012 Jun; 46(3):701-9. PubMed ID: 22426388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
    Zhao J; Fu Y; Yasvoina M; Shao P; Hitt B; O'Connor T; Logan S; Maus E; Citron M; Berry R; Binder L; Vassar R
    J Neurosci; 2007 Apr; 27(14):3639-49. PubMed ID: 17409228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.
    Rojanathammanee L; Floden AM; Manocha GD; Combs CK
    J Neuroinflammation; 2015 Mar; 12():42. PubMed ID: 25889879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
    Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
    Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective role of γ-enolase in microglia in a mouse model of Alzheimer's disease is regulated by cathepsin X.
    Hafner A; Glavan G; Obermajer N; Živin M; Schliebs R; Kos J
    Aging Cell; 2013 Aug; 12(4):604-14. PubMed ID: 23621429
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Park MH; Lee M; Nam G; Kim M; Kang J; Choi BJ; Jeong MS; Park KH; Han WH; Tak E; Kim MS; Lee J; Lin Y; Lee YH; Song IS; Choi MK; Lee JY; Jin HK; Bae JS; Lim MH
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23426-23436. PubMed ID: 31685616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.